About tRNA (cytosine(38)-C(5))-methyltransferase
tRNA (cytosine(38)-C(5))-methyltransferase (TRDMT1) is a protein
from Homo sapiens identified by UniProt accession
O14717, 391 residues long.
MolForge cross-references it against 0 known binders and
115 disease associations.
Target properties
| Protein name | tRNA (cytosine(38)-C(5))-methyltransferase |
| UniProt accession | O14717 |
| Gene | TRDMT1 |
| Organism | Homo sapiens |
| Length | 391 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (115)
Diseases linked to this target (Open Targets).
- platelet count · score 0.44
- Red cell distribution width · score 0.40
- platelet component distribution width · score 0.38
- neurodegenerative disease · score 0.37
- mean corpuscular volume · score 0.36
- platelet crit · score 0.36
- HbA1c measurement · score 0.31
- hemoglobin A1 measurement · score 0.31
- total cholesterol measurement · score 0.29
- homocysteine measurement · score 0.28
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O14717-F1 | alphafold | PREDICTED | 87.06 | — |
Amino-acid sequence (391 residues)
MEPLRVLELY SGVGGMHHAL RESCIPAQVV AAIDVNTVAN EVYKYNFPHT QLLAKTIEGI TLEEFDRLSF DMILMSPPCQ PFTRIGRQGD MTDSRTNSFL HILDILPRLQ KLPKYILLEN VKGFEVSSTR DLLIQTIENC GFQYQEFLLS PTSLGIPNSR LRYFLIAKLQ SEPLPFQAPG QVLMEFPKIE SVHPQKYAMD VENKIQEKNV EPNISFDGSI QCSGKDAILF KLETAEEIHR KNQQDSDLSV KMLKDFLEDD TDVNQYLLPP KSLLRYALLL DIVQPTCRRS VCFTKGYGSY IEGTGSVLQT AEDVQVENIY KSLTNLSQEE QITKLLILKL RYFTPKEIAN LLGFPPEFGF PEKITVKQRY RLLGNSLNVH VVAKLIKILY E
Explore tRNA (cytosine(38)-C(5))-methyltransferase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets